Reaction Details |
| Report a problem with these data |
Target | Transcriptional regulator ERG |
---|
Ligand | BDBM251928 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | hERG Inhibition Assay |
---|
IC50 | 20000±n/a nM |
---|
Citation | Hoveyda, HR; Dutheuil, G; Fraser, GL; Roy, M; Bousmaqui, ME; Batt, F Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof US Patent US10065961 Publication Date 9/4/2018 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Transcriptional regulator ERG |
---|
Name: | Transcriptional regulator ERG |
Synonyms: | ERG | ERG_HUMAN | Transforming protein ERG |
Type: | PROTEIN |
Mol. Mass.: | 54615.84 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1335569 |
Residue: | 486 |
Sequence: | MIQTVPDPAAHIKEALSVVSEDQSLFECAYGTPHLAKTEMTASSSSDYGQTSKMSPRVPQ
QDWLSQPPARVTIKMECNPSQVNGSRNSPDECSVAKGGKMVGSPDTVGMNYGSYMEEKHM
PPPNMTTNERRVIVPADPTLWSTDHVRQWLEWAVKEYGLPDVNILLFQNIDGKELCKMTK
DDFQRLTPSYNADILLSHLHYLRETPLPHLTSDDVDKALQNSPRLMHARNTGGAAFIFPN
TSVYPEATQRITTRPDLPYEPPRRSAWTGHGHPTPQSKAAQPSPSTVPKTEDQRPQLDPY
QILGPTSSRLANPGSGQIQLWQFLLELLSDSSNSSCITWEGTNGEFKMTDPDEVARRWGE
RKSKPNMNYDKLSRALRYYYDKNIMTKVHGKRYAYKFDFHGIAQALQPHPPESSLYKYPS
DLPYMGSYHAHPQKMNFVAPHPPALPVTSSSFFAAPNPYWNSPTGGIYPNTRLPTSHMPS
HLGTYY
|
|
|
BDBM251928 |
---|
n/a |
---|
Name | BDBM251928 |
Synonyms: | US10065961, Compound 31 | US10683295, Compound 31 | US10941151, Compound 31 | US9475814, 31 |
Type | Small organic molecule |
Emp. Form. | C22H19N5O2S |
Mol. Mass. | 417.484 |
SMILES | C[C@H]1N(CCn2c1nnc2-c1cccc(O)n1)C(=O)c1ccc(cc1)-c1cccs1 |r| |
Structure |
|